Stereotaxis wins FDA clearance for Synchrony system, launches platform.
Share this article
Corporate
Score 35
Bullish
Stereotaxis wins FDA clearance for Synchrony system, launches platform
Apr 06, 2026 12:11 UTC
STXS
Short term
Related Articles
Score 55
Oracle names Schneider Electric’s Maxson as CFO amid soaring AI spending
Apr 06, 14:25
Score 45
BlackRock files for Nasdaq-100 fund, expanding competition with Invesco
Apr 06, 14:25
Score 35
Treasury designates BNY as financial agent for Trump accounts
Apr 06, 14:24
Score 35
Bullish
UBS reiterates Buy on Ulta Beauty stock citing sustainable growth
Apr 06, 14:21
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.